RDIF has tied up with nearly a dozen contract manufacturers with idle capacity to produce some 1.5 billion doses of Sputnik V annually, more than what Serum and Bharat Biotech will jointly produce.
For the International Women’s Day, we celebrate the 50 women who featured in our Most Powerful Women (MPW) in Business list for the year 2020. Here’s the editor’s letter from that issue.
As India starts the second phase of its Covid-19 vaccine deployment, the question on the viability of its supply chain network, and its cold storage capability, has become more pertinent than ever.
In an exclusive interview, U.K. Secretary of State for International Trade Elizabeth Truss talks about a potential Free Trade Agreement between India and the U.K., and further areas of collaboration.
India began the first phase of the mass vaccination programme against Covid-19. Fortune India's photo team visited one session site in Gurugram where the campaign was in full swing.
Besides Covishield, four more Covid-19 vaccines are under preparation at the world’s largest vaccine company in Pune as demand from across the globe spikes.
The DCGI has given the nod for two vaccines and phase 1 of the vaccination process is expected to begin soon. Zydus Cadila’s vaccine candidate has also been cleared for phase 3 trials.
The preparations on the ground are in full swing, and the country is using the expertise and insights culled from its innumerable election processes to begin rolling out the Covid-19 vaccine.
Three firms have applied for emergency use authorisation in India as of now. AIIMS’ Amit Dinda, who is a part of the Global Coalition for Regulatory Science Research, explains the regulatory nuances.
